NCT00283634 A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00269828 A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. Status TERMINATED Phase PHASE3
NCT00259064 Iressa v BSC (Best Supportive Care) in First Line NSCLC Status COMPLETED Phase PHASE2/PHASE3
NCT00242801 Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study Status COMPLETED Phase PHASE3
NCT00153803 Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT00082472 Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) Status UNKNOWN Phase PHASE1/PHASE2
NCT00072618 Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients Status COMPLETED Phase PHASE1/PHASE2